Cyclacel Stock Probability of Future Stock Price Finishing Over 8.59

CYCC
 Stock
  

USD 0.81  0.04  5.19%   

Cyclacel Pharmaceuticals' future price is the expected price of Cyclacel Pharmaceuticals instrument. It is based on its current growth rate as well as the projected cash flow expected by the investors. This tool provides a mechanism to make assumptions about the upside potential and downside risk of Cyclacel Pharmaceuticals performance during a given time horizon utilizing its historical volatility.
  
Cyclacel Pharmaceuticals' implied volatility is one of the determining factors in the pricing options written on Cyclacel Pharmaceuticals. Implied volatility approximates the future value of Cyclacel Pharmaceuticals based on the option's current value. Options with high implied volatility have higher premiums and can be used to hedge the downside of investing in Cyclacel Pharmaceuticals over a specific time period. For example, 2022-12-16 PUT at $2.5 is a PUT option contract on Cyclacel Pharmaceuticals' common stock with a strick price of 2.5 expiring on 2022-12-16. The contract was not traded in recent days and, as of today, has 14 days remaining before the expiration. The option is currently trading at a bid price of $0.75, and an ask price of $2.0. The implied volatility as of the 2nd of December is 856.0983. View All Cyclacel options

Closest to current price Cyclacel long PUT Option Payoff at Expiration

Continue to Cyclacel Pharmaceuticals Backtesting, Cyclacel Pharmaceuticals Valuation, Cyclacel Pharmaceuticals Correlation, Cyclacel Pharmaceuticals Hype Analysis, Cyclacel Pharmaceuticals Volatility, Cyclacel Pharmaceuticals History as well as Cyclacel Pharmaceuticals Performance. Please specify Cyclacel Pharmaceuticals time horizon, a valid symbol (red box) and a target price (blue box) you would like Cyclacel Pharmaceuticals odds to be computed.

Cyclacel Pharmaceuticals Target Price Odds to finish over 8.59

The tendency of Cyclacel Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
Current PriceHorizonTarget PriceOdds to move over $ 8.59  or more in 90 days
 0.81 90 days 8.59 
close to zero percent
Based on a normal probability distribution, the odds of Cyclacel Pharmaceuticals to move over $ 8.59  or more in 90 days from now is close to zero percent (This Cyclacel Pharmaceuticals probability density function shows the probability of Cyclacel Stock to fall within a particular range of prices over 90 days) . Probability of Cyclacel Pharmaceuticals price to stay between its current price of $ 0.81  and $ 8.59  at the end of the 90-day period is about 97.0 .
Given the investment horizon of 90 days Cyclacel Pharmaceuticals has a beta of 0.45 suggesting as returns on the market go up, Cyclacel Pharmaceuticals average returns are expected to increase less than the benchmark. However, during the bear market, the loss on holding Cyclacel Pharmaceuticals will be expected to be much smaller as well. Additionally The company has a negative alpha, implying that the risk taken by holding this instrument is not justified. Cyclacel Pharmaceuticals is significantly underperforming NYSE Composite.
   Cyclacel Pharmaceuticals Price Density   
       Price  

Predictive Modules for Cyclacel Pharmaceuticals

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Cyclacel Pharmaceuticals. Regardless of method or technology, however, to accurately forecast the stock or bond market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.
Sophisticated investors, who have witnessed many market ups and downs, frequently view the market will even out over time. This tendency of Cyclacel Pharmaceuticals' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy. Please use the tools below to analyze the current value of Cyclacel Pharmaceuticals in the context of predictive analytics.
Hype
Prediction
LowEstimated ValueHigh
0.040.815.55
Details
Intrinsic
Valuation
LowReal ValueHigh
0.735.6010.34
Details
Naive
Forecast
LowNext ValueHigh
0.0157720.795.53
Details
4 Analysts
Consensus
LowTarget PriceHigh
17.0020.0024.00
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Cyclacel Pharmaceuticals. Your research has to be compared to or analyzed against Cyclacel Pharmaceuticals' peers to derive any actionable benefits. When done correctly, Cyclacel Pharmaceuticals' competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy towards taking a position in Cyclacel Pharmaceuticals.

Cyclacel Pharmaceuticals Risk Indicators

For the most part, the last 10-20 years have been a very volatile time for the stock market. Cyclacel Pharmaceuticals is not an exception. The market had few large corrections towards the Cyclacel Pharmaceuticals' value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Cyclacel Pharmaceuticals, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Cyclacel Pharmaceuticals within the framework of very fundamental risk indicators.
α
Alpha over NYSE Composite
-1.05
β
Beta against NYSE Composite0.45
σ
Overall volatility
0.24
Ir
Information ratio -0.23

Cyclacel Pharmaceuticals Alerts and Suggestions

In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Cyclacel Pharmaceuticals for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Cyclacel Pharmaceuticals can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.
Cyclacel Pharmaceuticals generated a negative expected return over the last 90 days
Cyclacel Pharmaceuticals has some characteristics of a very speculative penny stock
Cyclacel Pharmaceuticals has high historical volatility and very poor performance
Net Loss for the year was (18.89 M) with loss before overhead, payroll, taxes, and interest of (338 K).
Cyclacel Pharmaceuticals currently holds about 29.08 M in cash with (18.54 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 2.32, which can makes it an attractive takeover target, given it will continue generating positive cash flow.

Cyclacel Pharmaceuticals Price Density Drivers

Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Cyclacel Stock often depends not only on the future outlook of the current and potential Cyclacel Pharmaceuticals' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Cyclacel Pharmaceuticals' indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding3633385.00
Cash And Short Term Investments36559000.00

Cyclacel Pharmaceuticals Technical Analysis

Cyclacel Pharmaceuticals' future price can be derived by breaking down and analyzing its technical indicators over time. Cyclacel Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Cyclacel Pharmaceuticals. In general, you should focus on analyzing Cyclacel Stock price patterns and their correlations with different microeconomic environments and drivers.

Cyclacel Pharmaceuticals Predictive Forecast Models

Cyclacel Pharmaceuticals time-series forecasting models is one of many Cyclacel Pharmaceuticals' stock analysis techniquest aimed to predict future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Cyclacel Pharmaceuticals' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.

Things to note about Cyclacel Pharmaceuticals

Checking the ongoing alerts about Cyclacel Pharmaceuticals for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Cyclacel Pharmaceuticals help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
Cyclacel Pharmaceuticals generated a negative expected return over the last 90 days
Cyclacel Pharmaceuticals has some characteristics of a very speculative penny stock
Cyclacel Pharmaceuticals has high historical volatility and very poor performance
Net Loss for the year was (18.89 M) with loss before overhead, payroll, taxes, and interest of (338 K).
Cyclacel Pharmaceuticals currently holds about 29.08 M in cash with (18.54 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 2.32, which can makes it an attractive takeover target, given it will continue generating positive cash flow.
Continue to Cyclacel Pharmaceuticals Backtesting, Cyclacel Pharmaceuticals Valuation, Cyclacel Pharmaceuticals Correlation, Cyclacel Pharmaceuticals Hype Analysis, Cyclacel Pharmaceuticals Volatility, Cyclacel Pharmaceuticals History as well as Cyclacel Pharmaceuticals Performance. Note that the Cyclacel Pharmaceuticals information on this page should be used as a complementary analysis to other Cyclacel Pharmaceuticals' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Content Syndication module to quickly integrate customizable finance content to your own investment portal.

Complementary Tools for Cyclacel Stock analysis

When running Cyclacel Pharmaceuticals price analysis, check to measure Cyclacel Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cyclacel Pharmaceuticals is operating at the current time. Most of Cyclacel Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Cyclacel Pharmaceuticals' future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Cyclacel Pharmaceuticals' price. Additionally, you may evaluate how the addition of Cyclacel Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Go
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Go
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Go
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Go
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Go
Probability Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Go
Fundamental Analysis
View fundamental data based on most recent published financial statements
Go
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Go
Is Cyclacel Pharmaceuticals' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Cyclacel Pharmaceuticals. If investors know Cyclacel will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Cyclacel Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Market Capitalization
10.4 M
Return On Assets
(0.42) 
Return On Equity
(0.60) 
The market value of Cyclacel Pharmaceuticals is measured differently than its book value, which is the value of Cyclacel that is recorded on the company's balance sheet. Investors also form their own opinion of Cyclacel Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Cyclacel Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Cyclacel Pharmaceuticals' market value can be influenced by many factors that don't directly affect Cyclacel Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Cyclacel Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine Cyclacel Pharmaceuticals value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Cyclacel Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.